VU 0364439

CAS No. 1246086-78-1

VU 0364439( VU0364439, VU-0364439, VU 0364439 )

Catalog No. M17215 CAS No. 1246086-78-1

VU 0364439 is a mGlu4 positive allosteric modulator (C50: 19.8 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 81 In Stock
5MG 73 In Stock
10MG 117 In Stock
25MG 211 In Stock
50MG 330 In Stock
100MG 529 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    VU 0364439
  • Note
    Research use only, not for human use.
  • Brief Description
    VU 0364439 is a mGlu4 positive allosteric modulator (C50: 19.8 nM).
  • Description
    VU0364439 is a positive allosteric modulator (PAM) of mGlu4 receptors (EC50 = 19.8 nM in vitro for human mGlu4).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    VU0364439, VU-0364439, VU 0364439
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    Microtubule/Tubulin
  • Recptor
    mGluR4
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    1246086-78-1
  • Formula Weight
    422.29
  • Molecular Formula
    C18H13Cl2N3O3S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 50 mg/mL. 118.40 mM;
  • SMILES
    c1ccc(c(c1)NS(=O)(=O)c1c(cc(cc1)NC(=O)c1ccccn1)Cl)Cl
  • Chemical Name
    N-[3-Chloro-4-[[(2-chlorophenyl)amino]sulfonyl]phenyl]-2-pyridinecarboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Engers DW, et al. Bioorg Med Chem Lett, 2010, 20(17), 5175-5178.
molnova catalog
related products
  • KHS101 hydrochloride

    KHS101 is a TACC3 inhibitor and can selectively induce a neuronal differentiation phenotype.

  • Vinorelbine

    Vinorelbine (KW-2307) is a vinca alkaloid chemotherapy agent that inhibits cancer cell mitosis through interaction with tubulin.

  • Sovilnesib

    Sovilnesib is a kinesin-like protein KIF18A inhibitor (WO2020132648). Sovilnesib can be used for the research of cancer.